An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

27.9K views

Cited by 2

07:44 min

May 22nd, 2020

10.3791/61054-v

May 22nd, 2020

27.9K views

The electrochemiluminescence immunoassay (ECLIA) is a novel approach for quantitative detection of endogenous and exogenously applied MeCP2 protein variants, which produces highly quantitative, accurate and reproducible measurements with low intra- and inter-assay error over a wide working range. Here, the protocol for the MeCP2-ECLIA in a 96-well format is described.

Explore More Videos

Electrochemiluminescence Assay

Chapters in this video

0:04

Introduction

0:35

Preparing Solutions and Plates (Day 1)

1:50

Blocking and Sample Addition (Day 2)

3:42

Antibody Addition

5:17

Reading the Plate

6:10

Results: Accuracy and Consistency of MeCP2-ECLIA

7:20

Conclusion

Related Videos